Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7299
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    82.66
    -0.15 (-0.18%)
     
  • Bitcoin CAD

    88,305.12
    -3,091.91 (-3.38%)
     
  • CMC Crypto 200

    1,395.19
    -28.91 (-2.03%)
     
  • GOLD FUTURES

    2,328.70
    -9.70 (-0.41%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,484.50
    -180.00 (-1.02%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,967.77
    -492.31 (-1.28%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Here's Why Relmada Therapeutics Stock Popped Today

Here's Why Relmada Therapeutics Stock Popped Today

Shares of Relmada Therapeutics (NASDAQ: RLMD), a clinical-stage biopharmaceutical company, popped in response to a positive clinical trial readout with the company's lead candidate. Investors excited about REL-1017's positive human abuse potential trial results pushed the stock 37% higher at its peak this morning. Relmada Therapeutics has settled down since its early morning pop.